{"id":1516,"date":"2008-01-01T12:03:00","date_gmt":"2008-01-01T11:03:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2008\/neu-eingefuehrte-arzneimittel-2006"},"modified":"2008-01-01T12:03:00","modified_gmt":"2008-01-01T11:03:00","slug":"neu-eingefuehrte-arzneimittel-2006","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2008\/neu-eingefuehrte-arzneimittel-2006","title":{"rendered":"Neu eingef\u00fchrte Arzneimittel 2006"},"content":{"rendered":"<p>Der Arzneiverordnungs-Report 2007 (1) schildert die Verordnungen zu Lasten der Gesetzlichen Krankenversicherung (GKV) nach dem Arzneimittelversorgungs-Wirtschaftlichkeitsgesetz, das 2006 wirksam geworden ist. Die wichtigsten Elemente sind: \u00b7 die Zuzahlungsbefreiung f\u00fcr Arzneimittel, deren Apothekenverkaufspreis mindestens 30% unter dem Festbetrag liegt, \u00b7 die Anpassungen in den Festbetr\u00e4gen sowie \u00b7 der 10%ige Generikaabschlag in Verbindung mit dem Verbot von [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Der Arzneiverordnungs-Report 2007 (1) schildert die Verordnungen zu Lasten der Gesetzlichen Krankenversicherung (GKV) nach dem Arzneimittelversorgungs-Wirtschaftlichkeitsgesetz, das 2006 wirksam geworden ist. Die wichtigsten Elemente sind: \u00b7 die Zuzahlungsbefreiung f\u00fcr Arzneimittel, deren Apothekenverkaufspreis mindestens 30% unter dem Festbetrag liegt, \u00b7 die Anpassungen in den Festbetr\u00e4gen sowie \u00b7 der 10%ige Generikaabschlag in Verbindung mit dem Verbot von [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1159,2934,3564,495,1967,1436,343,523,524,3560,3561,3559,526,3563,458,3568,943,2803,2933,2941,2937,3566,3567,3558,3562,3565,937,1160,938,1111,3569,2100,2102,2098,1450,2670,1593,1161,3573,1438,3571,2988,3570,3572,352,989,1177,70,551,1439,3328,514,1335,3555,3557,2279,754,3554,2929,936,3524,954,803,802,1158,3556,520,521,2931],"class_list":["post-1516","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-adipositas","tag-akute-lymphoblastische-leukaemie","tag-alglucosidase-alfa","tag-angina-pectoris","tag-anthrazykline","tag-anti-parkinson-mittel","tag-antibiotika","tag-arzneimittelverordnungen","tag-arzneiverordnungen","tag-arzneiverordnungs-report-2007","tag-aethylenglykol-intoxikation","tag-blasenkarzinom","tag-buchbesprechung","tag-carbetocin","tag-chronische-myeloische-leukaemie","tag-clofarabin","tag-daptomycin","tag-dasatinib","tag-deferasirox","tag-dexrazoxan","tag-eisenueberladung","tag-entecavir","tag-ethylenglykol-intoxikation","tag-fomepizol","tag-gadofosveset","tag-galsulfase","tag-gastrointestinale-stromatumoren","tag-gewichtsreduktion","tag-gist","tag-hepatitis-b","tag-hexaminolevulinat","tag-hpv","tag-hpv-impfung","tag-humanes-papillom-virus","tag-hyperphosphataemie","tag-infektionen","tag-ivabradin","tag-koerpergewicht","tag-lanthankarbonat","tag-m-parkinson","tag-m-pompe","tag-makuladegeneration","tag-maroteaux-lamy-syndrom","tag-mukopolysaccharidose-vi","tag-multiple-sklerose","tag-natalizumab","tag-nierenzellkarzinom","tag-osteoporose","tag-parathormon","tag-parkinson-syndrom","tag-pegaptanib","tag-pulmonale-hypertonie","tag-rimonabant","tag-rotavirus-impfstoff-monovalent","tag-rotavirus-impfstoff-pentavalent","tag-rotigotin","tag-schmerzen","tag-sitaxentan","tag-sorafenib","tag-sunitinib","tag-thalassaemia-major","tag-tigecyclin","tag-tyrosinkinase-hemmer","tag-tyrosinkinase-inhibitoren","tag-uebergewicht","tag-uterusatonie","tag-verordnungsverhalten","tag-verschreibungsverhalten","tag-ziconotid"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1516"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1516\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1516"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1516"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}